Navigation Links
NREL to help convert methane to liquid diesel
Date:1/8/2013

University of Washington is taking the lead and focusing on genetically modifying the microbes. NREL will be in charge of fermentation to demonstrate the productivity of the microbes, both the natural organism and the genetically-altered varieties. NREL will also extract the lipids from the organisms and analyze the economic potential of the plan.

A third partner, Johnson-Matthey of the United Kingdom, will produce the catalysts that turn the lipids in the methane into fuel. And Illinois-based Lanza Tech, a pioneer in waste-to-fuels technology, has signed on to take the bench-scale plan to the commercial level, if it is successful.

"We'll be leveraging our decades of experience in producing biofuels and lipids, which in the past we've typically done via algae," said Phil Pienkos, NREL's principle investigator on the liquid to diesel project. "Here, we'll be applying it to a brand new feedstock, natural gas, which is recognized as being critically important to the United States."

The team will start with microorganisms that grow naturally on methane, a component of natural gas, and which have a natural ability to make lipids from the methane. Unfortunately, the enzymes can't naturally produce enough lipids to make a project economically feasible. So they need some help from genetics. A goal of this project is to genetically engineer that microorganism to both increase the amount of membrane lipids and to get the microorganism to produce non-phosphorous-based lipids that are more readily converted to fuels.

The end product would be a fuel intermediate that then could be piped to a refinery for final processing into diesel or jet fuel. "It would be a good feedstock for a refinery," Pienkos said.

ARPA-E's goal is to see the research projects turned into commercial successes, said Rich Bolin, Senior Project Leader for the Partnership Development Group at NREL's National Bioenergy Center.

"If things go well, at the
'/>"/>

Contact: David Glickson
david.glickson@nrel.gov
303-275-4097
DOE/National Renewable Energy Laboratory
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Hybrid copper-gold nanoparticles convert CO2
2. Weizmann Institute solar technology to convert greenhouse gas into fuel
3. Mafic melts, methane seeps, 2 million waves, foreign magma, and the invisible hand
4. Ammonites found mini oases at ancient methane seeps
5. Study: Seeking Arctic methane has serious implications for Florida coastline
6. Study: Seeping Arctic methane has serious implications for Florida coastline
7. Stanford-Penn State scientists use microbes to make clean methane
8. Microbes make clean methane
9. Are methane hydrates dissolving?
10. How methane becomes fish food
11. Study identifies prime source of ocean methane
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... BOSTON , May 21, 2015 ... scientific potential of music for health, today announced a ... (BerkleeICE) . The partnership will center on collaboration on ...  As a first step in the collaboration, The Sync ... course on "Music as Medicine" in the 2015-2016 academic ...
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
(Date:5/11/2015)... Ohio , May 11, 2015  Through a well-rounded ... Ohio had a strong showing at AUVSI,s Unmanned ... These representatives of Ohio,s UAS industry ... and abroad from all points along the UAS ecosystem. ... Development Coalition,s (DDC) Vice President for Aerospace Rich Knoll ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3Global Genetic Testing Market Outlook 2018 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... made up of both hard and soft materials to ... the first step toward helping patients who have suffered ... a team of biomedical engineers. "Nerve injury in both ... major health problem," said Mohammad Reza Abidian, assistant professor ...
... drought to super storms, many wonder what the future holds ... conducted by researchers at the University of Tennessee, Knoxville, does ... will be hotter and wetter. Joshua Fu, a civil ... assistant, developed precise scales of cities which act as a ...
... 17, 2012)Millions of tiny Atlantic menhaden swim in the Chesapeake ... They are also the heart of a major fish oil ... declining. Thanks to a grant from the Lenfest Ocean ... for Environmental Science will investigate the balance between fishing for ...
Cached Biology News:Hybrid tunnel may help guide severed nerves back to health 2Hybrid tunnel may help guide severed nerves back to health 3University of Tennessee study predicts extreme climate in Eastern US 2New menhaden study will help identify balance between fishing and preserving Bay forage fish 2
(Date:6/1/2015)... , June 1, 2015  Turing Pharmaceuticals AG announced ... Oreste Salinas , MD, MSc,  has joined the ... Dr. Salinas, who holds a medical degree ... a record of significant accomplishments in the pharmaceutical ... Dr. Salinas has played a leadership role ...
(Date:6/1/2015)... Korea , June 1, 2015 This ... (GCBT) kicked off construction today on its biopharmaceutical facility ... Campus. The CA$315 million project represents one of the ... in the biopharmaceutical industry, giving place to ... albumin manufacturing plant in Canada . ...
(Date:6/1/2015)... June 1, 2015 GenomeDx Biosciences ... analysis platform, successfully classified various subtypes of ... of certain biomarkers, including one type associated ... unique genomic signature has potential as a ... chemotherapy in patients with muscle-invasive bladder cancers ...
(Date:6/1/2015)... , June 1, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... March 31, 2015.  Biorem,s complete 2015 first quarter financial statements and ... Financial Summary:Three-months ended March 31,(in CDN$,000 except per share ... 4,689 , 1,974 Gross profit , 1,531 ... Net earnings (loss) , 528 , (531) Basic ...
Breaking Biology Technology:Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Biorem Reports Increased Revenues and Earnings for First Quarter 2Biorem Reports Increased Revenues and Earnings for First Quarter 3
... SAN DIEGO, April 27 Orexigen(R) ... company focused on the treatment of obesity, today announced ... as Senior Vice President of Regulatory Affairs and Product ... 26 years of solid experience in biotechnology and pharmaceutical ...
... ETEX Corporation, a leading orthopaedic biomaterials company, announced ... sizes of Beta-bsm(TM) Injectable Paste and Gamma-bsm(TM) Moldable ... sizes. Both products are bone substitute materials based ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080424/NETH117LOGO ...
... - In connection with the requisition of Mr. Eugene ... to the annual and special meeting of shareholders of ... 2009 (the "Meeting"), the Concerned Shareholders announced today that ... as directors at the Meeting are Mr. Paul G. ...
Cached Biology Technology:Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program 2Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program 3Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program 4ETEX Corporation Announces FDA Clearance of Small Size Beta-bsm(TM) Injectable Paste and Gamma-bsm(TM) Moldable Putty 2Concerned Shareholders of Biovail Announce - Independent Nominees for Election to Biovail Board of Directors - A Focused Commitment to Governance at Biovail 2Concerned Shareholders of Biovail Announce - Independent Nominees for Election to Biovail Board of Directors - A Focused Commitment to Governance at Biovail 3Concerned Shareholders of Biovail Announce - Independent Nominees for Election to Biovail Board of Directors - A Focused Commitment to Governance at Biovail 4
... The Caliper Sciclone ALH 3000 workstation ... diagnostic applications, from Genomic and Proteomic Sample ... Assays. The modular design of the ... options and accessories to perfectly meet the ...
... The Sciclone inL10 Workstation from Caliper represents ... offering for the first time the ability ... automatically react to changing conditions. In ... in viscosity due to changes in temperature, ...
ID clarifier: non-treated with lid...
... Workstation fully automates pharmaceutical sample preparation ... sample transfer, mixing and dilutions. Capabilities ... detection. The Prelude performs these functions ... Part 11. The Prelude performs ...
Biology Products: